Results
Type
Country of origin
Qualifications

Ledipasvir | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Ledipasvir. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Maruti Futuristic Pharma Pvt Ltd

MOQ: 1 kg
Type: Producer
Origin: India
India
Apino Pharma Co., Ltd.

MOQ: 1 kg
Type: Producer
Origin: China
China
Shaoxing Hantai Pharma


Type: Trader
Origin: China
China
Mylan


Type: Producer
Origin: India
India
Natco Pharma


Type: Producer
Origin: India
India
PCAS


Type: Producer
Origin: France
France
Dalian Wista Pharma Co Ltd


Type: Producer
Origin: China
China
Beijing Mesochem Technology Co Ltd


Type: Producer
Origin: China
China

Looking for Ledipasvir 1256388-51-8?

API | Excipient name:
Ledipasvir 
Synonyms:
 
Cas Number:
1256388-51-8 
DrugBank number:
DB09027 
Unique Ingredient Identifier:
013TE6E4WV

About Ledipasvir

It's time for some technical information for the ones who understand chemistry: Ledipasvir is a direct acting antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients Treatment options for chronic Hepatitis C have advanced significantly since 20 with the development of Direct Acting Antivirals (DAAs) such as ledipasvir. More specifically, ledipasvir is an inhibitor of the Hepatitis C Virus (HCV) Non-Structural Protein 5A (NS5A), which is required for viral RNA replication and assembly of HCV virions. Although its exact mechanism of action is unknown, it is postulated to prevent hyperphosphorylation of NS5A which is required for viral protein production.

It is effective against genotypes 1a, 1b, 4a, and 5a and with a lesser activity against genotypes 2a and 3a of HCV. Ledipasvir and other direct acting antivirals are very potent options for the treatment of Hepatitis C, as they exhibit a high barrier to the development of resistance This is an important advantage relative to HCV drugs that target other viral enzymes such as the protease, for which rapid development of resistance has proven to be an important cause of therapeutic failure.

Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.

Ledipasvir manufacturers | traders | suppliers
We have 8 companies offering Ledipasvir from 3 different countries.

Get in contact with the supplier of your choice:

  • Maruti Futuristic Pharma Pvt Ltd from India
  • Apino Pharma Co., Ltd. from China
  • Mylan from India
  • Shaoxing Hantai Pharma from China
  • Natco Pharma from India
  • PCAS from France
  • Beijing Mesochem Technology Co Ltd from China
  • Dalian Wista Pharma Co Ltd from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.